><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>
<year>2015</year>
<source>Global Tuberculosis Report 2015.</source>
<publisher-name>World Health Organization</publisher-name>, <publisher-loc>Geneva, Switzerland</publisher-loc>.</mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinnijenhuis</surname><given-names>J.</given-names></name><name><surname>Oosting</surname><given-names>M.</given-names></name><name><surname>Joosten</surname><given-names>L. A.</given-names></name><name><surname>Netea</surname><given-names>M. G.</given-names></name><name><surname>Van Crevel</surname><given-names>R.</given-names></name></person-group>
<year>2011</year>
<article-title>Innate immune recognition of <italic>Mycobacterium tuberculosis.</italic></article-title>
<source>Clin. Dev. Immunol.</source>
<volume>2011</volume>: <fpage>405310</fpage>.<pub-id pub-id-type="pmid">21603213</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name></person-group>
<year>2001</year>
<article-title>Immunology of tuberculosis.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>19</volume>: <fpage>93</fpage>&#x02013;<lpage>129</lpage>.<pub-id pub-id-type="pmid">11244032</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>R. J.</given-names></name><name><surname>Jung</surname><given-names>Y. J.</given-names></name></person-group>
<year>2004</year>
<article-title>Immunity to tuberculosis.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>22</volume>: <fpage>599</fpage>&#x02013;<lpage>623</lpage>.<pub-id pub-id-type="pmid">15032590</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name></person-group>
<year>2009</year>
<article-title>Cell-mediated immune responses in tuberculosis.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>27</volume>: <fpage>393</fpage>&#x02013;<lpage>422</lpage>.<pub-id pub-id-type="pmid">19302046</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name><name><surname>Redford</surname><given-names>P. S.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Bloom</surname><given-names>C. I.</given-names></name><name><surname>Wilkinson</surname><given-names>R. J.</given-names></name><name><surname>Berry</surname><given-names>M. P.</given-names></name></person-group>
<year>2013</year>
<article-title>The immune response in tuberculosis.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>31</volume>: <fpage>475</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="pmid">23516984</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Goldstein</surname><given-names>M. M.</given-names></name><name><surname>Triebold</surname><given-names>K. J.</given-names></name><name><surname>Sypek</surname><given-names>J.</given-names></name><name><surname>Wolf</surname><given-names>S.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group>
<year>1995</year>
<article-title>IL-12 increases resistance of BALB/c mice to <italic>Mycobacterium tuberculosis</italic> infection.</article-title>
<source>J. Immunol.</source>
<volume>155</volume>: <fpage>2515</fpage>&#x02013;<lpage>2524</lpage>.<pub-id pub-id-type="pmid">7650381</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name><name><surname>Magram</surname><given-names>J.</given-names></name><name><surname>Ferrante</surname><given-names>J.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group>
<year>1997</year>
<article-title>Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with <italic>Mycobacterium tuberculosis.</italic></article-title>
<source>J. Exp. Med.</source>
<volume>186</volume>: <fpage>39</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">9206995</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>J. L.</given-names></name><name><surname>Abel</surname><given-names>L.</given-names></name></person-group>
<year>2002</year>
<article-title>Genetic dissection of immunity to mycobacteria: the human model.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>20</volume>: <fpage>581</fpage>&#x02013;<lpage>620</lpage>.<pub-id pub-id-type="pmid">11861613</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name><name><surname>Dalton</surname><given-names>D. K.</given-names></name><name><surname>Stewart</surname><given-names>T. A.</given-names></name><name><surname>Griffin</surname><given-names>J. P.</given-names></name><name><surname>Russell</surname><given-names>D. G.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group>
<year>1993</year>
<article-title>Disseminated tuberculosis in interferon &#x003b3; gene-disrupted mice.</article-title>
<source>J. Exp. Med.</source>
<volume>178</volume>: <fpage>2243</fpage>&#x02013;<lpage>2247</lpage>.<pub-id pub-id-type="pmid">8245795</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Triebold</surname><given-names>K. J.</given-names></name><name><surname>Dalton</surname><given-names>D. K.</given-names></name><name><surname>Stewart</surname><given-names>T. A.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group>
<year>1993</year>
<article-title>An essential role for interferon &#x003b3; in resistance to <italic>Mycobacterium tuberculosis</italic> infection.</article-title>
<source>J. Exp. Med.</source>
<volume>178</volume>: <fpage>2249</fpage>&#x02013;<lpage>2254</lpage>.<pub-id pub-id-type="pmid">7504064</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>J. D.</given-names></name><name><surname>North</surname><given-names>R. J.</given-names></name><name><surname>LaCourse</surname><given-names>R.</given-names></name><name><surname>Mudgett</surname><given-names>J. S.</given-names></name><name><surname>Shah</surname><given-names>S. K.</given-names></name><name><surname>Nathan</surname><given-names>C. F.</given-names></name></person-group>
<year>1997</year>
<article-title>Identification of nitric oxide synthase as a protective locus against tuberculosis.</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>94</volume>: <fpage>5243</fpage>&#x02013;<lpage>5248</lpage>.<pub-id pub-id-type="pmid">9144222</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Jung</surname><given-names>Y. J.</given-names></name><name><surname>Tyagi</surname><given-names>S.</given-names></name><name><surname>Gennaro</surname><given-names>M. L.</given-names></name><name><surname>North</surname><given-names>R. J.</given-names></name></person-group>
<year>2003</year>
<article-title>Expression of Th1-mediated immunity in mouse lungs induces a <italic>Mycobacterium tuberculosis</italic> transcription pattern characteristic of nonreplicating persistence.</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>100</volume>: <fpage>241</fpage>&#x02013;<lpage>246</lpage>.<pub-id pub-id-type="pmid">12506197</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanga</surname><given-names>C. A.</given-names></name><name><surname>Mohan</surname><given-names>V. P.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Alland</surname><given-names>D.</given-names></name><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name></person-group>
<year>2001</year>
<article-title>The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of <italic>Mycobacterium tuberculosis</italic> in mice.</article-title>
<source>Infect. Immun.</source>
<volume>69</volume>: <fpage>7711</fpage>&#x02013;<lpage>7717</lpage>.<pub-id pub-id-type="pmid">11705952</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmona</surname><given-names>J.</given-names></name><name><surname>Cruz</surname><given-names>A.</given-names></name><name><surname>Moreira-Teixeira</surname><given-names>L.</given-names></name><name><surname>Sousa</surname><given-names>C.</given-names></name><name><surname>Sousa</surname><given-names>J.</given-names></name><name><surname>Osorio</surname><given-names>N. S.</given-names></name><name><surname>Saraiva</surname><given-names>A. L.</given-names></name><name><surname>Svenson</surname><given-names>S.</given-names></name><name><surname>Kallenius</surname><given-names>G.</given-names></name><name><surname>Pedrosa</surname><given-names>J.</given-names></name><etal/></person-group>
<year>2013</year>
<article-title><italic>Mycobacterium tuberculosis</italic> strains are differentially recognized by TLRs with an impact on the immune response.</article-title>
<source>PLoS One</source>
<volume>8</volume>: <fpage>e67277</fpage>.<pub-id pub-id-type="pmid">23840651</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F.</given-names></name><name><surname>Mayer-Barber</surname><given-names>K.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>Wack</surname><given-names>A.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group>
<year>2015</year>
<article-title>Type I interferons in infectious disease.</article-title>
<source>Nat. Rev. Immunol.</source>
<volume>15</volume>: <fpage>87</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">25614319</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stifter</surname><given-names>S. A.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name></person-group>
<year>2015</year>
<article-title>Interfering with immunity: detrimental role of type I IFNs during infection.</article-title>
<source>J. Immunol.</source>
<volume>194</volume>: <fpage>2455</fpage>&#x02013;<lpage>2465</lpage>.<pub-id pub-id-type="pmid">25747907</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C.</given-names></name><name><surname>Tsenova</surname><given-names>L.</given-names></name><name><surname>Bergtold</surname><given-names>A.</given-names></name><name><surname>Freeman</surname><given-names>S.</given-names></name><name><surname>Tovey</surname><given-names>M.</given-names></name><name><surname>Musser</surname><given-names>J. M.</given-names></name><name><surname>Barry</surname><given-names>C. E.</given-names><suffix>III</suffix></name><name><surname>Freedman</surname><given-names>V. H.</given-names></name><name><surname>Kaplan</surname><given-names>G.</given-names></name></person-group>
<year>2001</year>
<article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-&#x003b1;/&#x003b2;.</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>98</volume>: <fpage>5752</fpage>&#x02013;<lpage>5757</lpage>.<pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C.</given-names></name><name><surname>Tsenova</surname><given-names>L.</given-names></name><name><surname>Freeman</surname><given-names>S.</given-names></name><name><surname>Barczak</surname><given-names>A. K.</given-names></name><name><surname>Tovey</surname><given-names>M.</given-names></name><name><surname>Murray</surname><given-names>P. J.</given-names></name><name><surname>Barry</surname><given-names>C.</given-names></name><name><surname>Kaplan</surname><given-names>G.</given-names></name></person-group>
<year>2005</year>
<article-title>Hypervirulent <italic>M. tuberculosis</italic> W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway.</article-title>
<source>J. Interferon Cytokine Res.</source>
<volume>25</volume>: <fpage>694</fpage>&#x02013;<lpage>701</lpage>.<pub-id pub-id-type="pmid">16318583</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordway</surname><given-names>D.</given-names></name><name><surname>Henao-Tamayo</surname><given-names>M.</given-names></name><name><surname>Harton</surname><given-names>M.</given-names></name><name><surname>Palanisamy</surname><given-names>G.</given-names></name><name><surname>Troudt</surname><given-names>J.</given-names></name><name><surname>Shanley</surname><given-names>C.</given-names></name><name><surname>Basaraba</surname><given-names>R. J.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group>
<year>2007</year>
<article-title>The hypervirulent <italic>Mycobacterium tuberculosis</italic> strain HN878 induces a potent TH1 response followed by rapid down-regulation.</article-title>
<source>J. Immunol.</source>
<volume>179</volume>: <fpage>522</fpage>&#x02013;<lpage>531</lpage>.<pub-id pub-id-type="pmid">17579073</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>S. A.</given-names></name><name><surname>Johndrow</surname><given-names>J. E.</given-names></name><name><surname>Manzanillo</surname><given-names>P.</given-names></name><name><surname>Cox</surname><given-names>J. S.</given-names></name></person-group>
<year>2007</year>
<article-title>The type I IFN response to infection with <italic>Mycobacterium tuberculosis</italic> requires ESX-1-mediated secretion and contributes to pathogenesis.</article-title>
<source>J. Immunol.</source>
<volume>178</volume>: <fpage>3143</fpage>&#x02013;<lpage>3152</lpage>.<pub-id pub-id-type="pmid">17312162</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A.</given-names></name><name><surname>Yeremeev</surname><given-names>V.</given-names></name><name><surname>Nouailles</surname><given-names>G.</given-names></name><name><surname>Weiner</surname><given-names>J.</given-names><suffix>III</suffix></name><name><surname>J&#x000f6;rg</surname><given-names>S.</given-names></name><name><surname>Heinemann</surname><given-names>E.</given-names></name><name><surname>Oberbeck-M&#x000fc;ller</surname><given-names>D.</given-names></name><name><surname>Knaul</surname><given-names>J. K.</given-names></name><name><surname>Vogelzang</surname><given-names>A.</given-names></name><name><surname>Reece</surname><given-names>S. T.</given-names></name><etal/></person-group>
<year>2014</year>
<article-title>Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics.</article-title>
<source>Eur. J. Immunol.</source>
<volume>44</volume>: <fpage>2380</fpage>&#x02013;<lpage>2393</lpage>.<pub-id pub-id-type="pmid">24782112</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>L. R.</given-names></name><name><surname>Gigliotti Rothfuchs</surname><given-names>A.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>R.</given-names></name><name><surname>Roff&#x000ea;</surname><given-names>E.</given-names></name><name><surname>Cheever</surname><given-names>A. W.</given-names></name><name><surname>Bafica</surname><given-names>A.</given-names></name><name><surname>Salazar</surname><given-names>A. M.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group>
<year>2010</year>
<article-title>Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.</article-title>
<source>J. Clin. Invest.</source>
<volume>120</volume>: <fpage>1674</fpage>&#x02013;<lpage>1682</lpage>.<pub-id pub-id-type="pmid">20389020</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Ewbank</surname><given-names>J.</given-names></name><name><surname>Rajsbaum</surname><given-names>R.</given-names></name><name><surname>Stavropoulos</surname><given-names>E.</given-names></name><name><surname>Martirosyan</surname><given-names>A.</given-names></name><name><surname>Redford</surname><given-names>P. S.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>Saraiva</surname><given-names>M.</given-names></name><name><surname>Tsichlis</surname><given-names>P.</given-names></name><etal/></person-group>
<year>2013</year>
<article-title>TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production.</article-title>
<source>J. Immunol.</source>
<volume>191</volume>: <fpage>1732</fpage>&#x02013;<lpage>1743</lpage>.<pub-id pub-id-type="pmid">23842752</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Andrade</surname><given-names>B. B.</given-names></name><name><surname>Oland</surname><given-names>S. D.</given-names></name><name><surname>Amaral</surname><given-names>E. P.</given-names></name><name><surname>Barber</surname><given-names>D. L.</given-names></name><name><surname>Gonzales</surname><given-names>J.</given-names></name><name><surname>Derrick</surname><given-names>S. C.</given-names></name><name><surname>Shi</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>N. P.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><etal/></person-group>
<year>2014</year>
<article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.</article-title>
<source>Nature</source>
<volume>511</volume>: <fpage>99</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">24990750</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>P. S.</given-names></name><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Stavropoulos</surname><given-names>E.</given-names></name><name><surname>Wack</surname><given-names>A.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group>
<year>2014</year>
<article-title>Influenza A virus impairs control of <italic>Mycobacterium tuberculosis</italic> coinfection through a type I interferon receptor-dependent pathway.</article-title>
<source>J. Infect. Dis.</source>
<volume>209</volume>: <fpage>270</fpage>&#x02013;<lpage>274</lpage>.<pub-id pub-id-type="pmid">23935205</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>M. P.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Bloch</surname><given-names>S. A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><name><surname>Wilkinson</surname><given-names>K. A.</given-names></name><name><surname>Banchereau</surname><given-names>R.</given-names></name><name><surname>Skinner</surname><given-names>J.</given-names></name><name><surname>Wilkinson</surname><given-names>R. J.</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.</article-title>
<source>Nature</source>
<volume>466</volume>: <fpage>973</fpage>&#x02013;<lpage>977</lpage>.<pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J.</given-names></name><name><surname>Repsilber</surname><given-names>D.</given-names></name><name><surname>Parida</surname><given-names>S. K.</given-names></name><name><surname>Stanley</surname><given-names>K.</given-names></name><name><surname>Roberts</surname><given-names>T.</given-names></name><name><surname>Black</surname><given-names>G.</given-names></name><name><surname>Walzl</surname><given-names>G.</given-names></name><name><surname>Kaufmann</surname><given-names>S. H.</given-names></name></person-group>
<year>2011</year>
<article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis.</article-title>
<source>Genes Immun.</source>
<volume>12</volume>: <fpage>15</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">20861863</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>T. H.</given-names></name><name><surname>Dass</surname><given-names>R. H.</given-names></name><name><surname>Yang</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>M. M.</given-names></name><name><surname>Wong</surname><given-names>H. E.</given-names></name><name><surname>Sahiratmadja</surname><given-names>E.</given-names></name><name><surname>Khor</surname><given-names>C. C.</given-names></name><name><surname>Alisjahbana</surname><given-names>B.</given-names></name><name><surname>van Crevel</surname><given-names>R.</given-names></name><name><surname>Marzuki</surname><given-names>S.</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis.</article-title>
<source>PLoS One</source>
<volume>7</volume>: <fpage>e45839</fpage>.<pub-id pub-id-type="pmid">23029268</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cliff</surname><given-names>J. M.</given-names></name><name><surname>Lee</surname><given-names>J. S.</given-names></name><name><surname>Constantinou</surname><given-names>N.</given-names></name><name><surname>Cho</surname><given-names>J. E.</given-names></name><name><surname>Clark</surname><given-names>T. G.</given-names></name><name><surname>Ronacher</surname><given-names>K.</given-names></name><name><surname>King</surname><given-names>E. C.</given-names></name><name><surname>Lukey</surname><given-names>P. T.</given-names></name><name><surname>Duncan</surname><given-names>K.</given-names></name><name><surname>Van Helden</surname><given-names>P. D.</given-names></name><etal/></person-group>
<year>2013</year>
<article-title>Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response.</article-title>
<source>J. Infect. Dis.</source>
<volume>207</volume>: <fpage>18</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">22872737</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>C. I.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>Berry</surname><given-names>M. P.</given-names></name><name><surname>Wilkinson</surname><given-names>K. A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><name><surname>Rozakeas</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Rossello-Urgell</surname><given-names>J.</given-names></name><name><surname>Chaussabel</surname><given-names>D.</given-names></name><name><surname>Banchereau</surname><given-names>J.</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.</article-title>
<source>PLoS One</source>
<volume>7</volume>: <fpage>e46191</fpage>.<pub-id pub-id-type="pmid">23056259</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Andrade</surname><given-names>B. B.</given-names></name><name><surname>Barber</surname><given-names>D. L.</given-names></name><name><surname>Hieny</surname><given-names>S.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name><name><surname>Caspar</surname><given-names>P.</given-names></name><name><surname>Oland</surname><given-names>S.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group>
<year>2011</year>
<article-title>Innate and adaptive interferons suppress IL-1&#x003b1; and IL-1&#x003b2; production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection.</article-title>
<source>Immunity</source>
<volume>35</volume>: <fpage>1023</fpage>&#x02013;<lpage>1034</lpage>.<pub-id pub-id-type="pmid">22195750</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Ewbank</surname><given-names>J.</given-names></name><name><surname>Howes</surname><given-names>A.</given-names></name><name><surname>Moreira-Teixeira</surname><given-names>L.</given-names></name><name><surname>Martirosyan</surname><given-names>A.</given-names></name><name><surname>Ghilardi</surname><given-names>N.</given-names></name><name><surname>Saraiva</surname><given-names>M.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group>
<year>2014</year>
<article-title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-&#x003b3; for production of IL-12 and bacterial killing in <italic>Mycobacterium tuberculosis</italic>-infected macrophages.</article-title>
<source>J. Immunol.</source>
<volume>193</volume>: <fpage>3600</fpage>&#x02013;<lpage>3612</lpage>.<pub-id pub-id-type="pmid">25187652</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A.</given-names></name><name><surname>Cardone</surname><given-names>M.</given-names></name><name><surname>Thompson</surname><given-names>R.</given-names></name><name><surname>Shenderov</surname><given-names>K.</given-names></name><name><surname>Kirschman</surname><given-names>K. D.</given-names></name><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Myers</surname><given-names>T. G.</given-names></name><name><surname>Rabin</surname><given-names>R. L.</given-names></name><name><surname>Trinchieri</surname><given-names>G.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name></person-group>
<year>2011</year>
<article-title><italic>Mycobacterium tuberculosis</italic> triggers host type I IFN signaling to regulate IL-1&#x003b2; production in human macrophages.</article-title>
<source>J. Immunol.</source>
<volume>187</volume>: <fpage>2540</fpage>&#x02013;<lpage>2547</lpage>.<pub-id pub-id-type="pmid">21784976</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariotti</surname><given-names>S.</given-names></name><name><surname>Teloni</surname><given-names>R.</given-names></name><name><surname>Iona</surname><given-names>E.</given-names></name><name><surname>Fattorini</surname><given-names>L.</given-names></name><name><surname>Romagnoli</surname><given-names>G.</given-names></name><name><surname>Gagliardi</surname><given-names>M. C.</given-names></name><name><surname>Orefici</surname><given-names>G.</given-names></name><name><surname>Nisini</surname><given-names>R.</given-names></name></person-group>
<year>2004</year>
<article-title><italic>Mycobacterium tuberculosis</italic> diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells.</article-title>
<source>Infect. Immun.</source>
<volume>72</volume>: <fpage>4385</fpage>&#x02013;<lpage>4392</lpage>.<pub-id pub-id-type="pmid">15271894</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group>
<year>2015</year>
<article-title>Cytokine and lipid mediator networks in tuberculosis.</article-title>
<source>Immunol. Rev.</source>
<volume>264</volume>: <fpage>264</fpage>&#x02013;<lpage>275</lpage>.<pub-id pub-id-type="pmid">25703565</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>R. M.</given-names></name><name><surname>Graeber</surname><given-names>T. G.</given-names></name><name><surname>Krutzik</surname><given-names>S. R.</given-names></name><name><surname>Montoya</surname><given-names>D.</given-names></name><name><surname>Schenk</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>D. J.</given-names></name><name><surname>Komisopoulou</surname><given-names>E.</given-names></name><name><surname>Kelly-Scumpia</surname><given-names>K.</given-names></name><name><surname>Chun</surname><given-names>R.</given-names></name><name><surname>Iyer</surname><given-names>S. S.</given-names></name><etal/></person-group>
<year>2013</year>
<article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses.</article-title>
<source>Science</source>
<volume>339</volume>: <fpage>1448</fpage>&#x02013;<lpage>1453</lpage>.<pub-id pub-id-type="pmid">23449998</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Paus</surname><given-names>R. A.</given-names></name><name><surname>van Wengen</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>I.</given-names></name><name><surname>Visser</surname><given-names>M.</given-names></name><name><surname>Verdegaal</surname><given-names>E. M.</given-names></name><name><surname>van Dissel</surname><given-names>J. T.</given-names></name><name><surname>van de Vosse</surname><given-names>E.</given-names></name></person-group>
<year>2013</year>
<article-title>Inhibition of the type I immune responses of human monocytes by IFN-&#x003b1; and IFN-&#x003b2;.</article-title>
<source>Cytokine</source>
<volume>61</volume>: <fpage>645</fpage>&#x02013;<lpage>655</lpage>.<pub-id pub-id-type="pmid">23299081</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>L.</given-names></name><name><surname>Wolf</surname><given-names>A. J.</given-names></name><name><surname>Ernst</surname><given-names>J. D.</given-names></name></person-group>
<year>2012</year>
<article-title>Dynamic roles of type I and type II IFNs in early infection with <italic>Mycobacterium tuberculosis.</italic></article-title>
<source>J. Immunol.</source>
<volume>188</volume>: <fpage>6205</fpage>&#x02013;<lpage>6215</lpage>.<pub-id pub-id-type="pmid">22566567</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>C. M.</given-names></name><name><surname>Jyonouchi</surname><given-names>H.</given-names></name><name><surname>Kotenko</surname><given-names>S. V.</given-names></name><name><surname>Smirnov</surname><given-names>S. V.</given-names></name><name><surname>Patel</surname><given-names>R.</given-names></name><name><surname>Aguila</surname><given-names>H.</given-names></name><name><surname>McSherry</surname><given-names>G.</given-names></name><name><surname>Dashefsky</surname><given-names>B.</given-names></name><name><surname>Holland</surname><given-names>S. M.</given-names></name></person-group>
<year>2007</year>
<article-title>Adjunctive treatment of disseminated <italic>Mycobacterium avium</italic> complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency.</article-title>
<source>Eur. J. Pediatr.</source>
<volume>166</volume>: <fpage>981</fpage>&#x02013;<lpage>985</lpage>.<pub-id pub-id-type="pmid">17120031</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name><name><surname>Pearl</surname><given-names>J. E.</given-names></name><name><surname>Brooks</surname><given-names>J. V.</given-names></name><name><surname>Ehlers</surname><given-names>S.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group>
<year>2000</year>
<article-title>Expression of the nitric oxide synthase 2 gene is not essential for early control of <italic>Mycobacterium tuberculosis</italic> in the murine lung.</article-title>
<source>Infect. Immun.</source>
<volume>68</volume>: <fpage>6879</fpage>&#x02013;<lpage>6882</lpage>.<pub-id pub-id-type="pmid">11083808</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>Y. J.</given-names></name><name><surname>LaCourse</surname><given-names>R.</given-names></name><name><surname>Ryan</surname><given-names>L.</given-names></name><name><surname>North</surname><given-names>R. J.</given-names></name></person-group>
<year>2002</year>
<article-title>Virulent but not avirulent <italic>Mycobacterium tuberculosis</italic> can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice.</article-title>
<source>J. Exp. Med.</source>
<volume>196</volume>: <fpage>991</fpage>&#x02013;<lpage>998</lpage>.<pub-id pub-id-type="pmid">12370260</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>M. S.</given-names></name><name><surname>Fl&#x000f3;rido</surname><given-names>M.</given-names></name><name><surname>Pais</surname><given-names>T. F.</given-names></name><name><surname>Appelberg</surname><given-names>R.</given-names></name></person-group>
<year>1999</year>
<article-title>Improved clearance of <italic>Mycobacterium avium</italic> upon disruption of the inducible nitric oxide synthase gene.</article-title>
<source>J. Immunol.</source>
<volume>162</volume>: <fpage>6734</fpage>&#x02013;<lpage>6739</lpage>.<pub-id pub-id-type="pmid">10352292</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>F.</given-names></name><name><surname>Koedel</surname><given-names>U.</given-names></name><name><surname>Kastenbauer</surname><given-names>S.</given-names></name><name><surname>Pfister</surname><given-names>H. W.</given-names></name></person-group>
<year>2001</year>
<article-title>Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown.</article-title>
<source>J. Infect. Dis.</source>
<volume>183</volume>: <fpage>1749</fpage>&#x02013;<lpage>1759</lpage>.<pub-id pub-id-type="pmid">11372027</pub-id></mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>C.</given-names></name><name><surname>Thomas</surname><given-names>S.</given-names></name><name><surname>Filak</surname><given-names>H.</given-names></name><name><surname>Henson</surname><given-names>P. M.</given-names></name><name><surname>Lenz</surname><given-names>L. L.</given-names></name></person-group>
<year>2012</year>
<article-title>Nitric oxide increases susceptibility of Toll-like receptor-activated macrophages to spreading <italic>Listeria monocytogenes.</italic></article-title>
<source>Immunity</source>
<volume>36</volume>: <fpage>807</fpage>&#x02013;<lpage>820</lpage>.<pub-id pub-id-type="pmid">22542147</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>Q. W.</given-names></name><name><surname>Nathan</surname><given-names>C.</given-names></name></person-group>
<year>1997</year>
<article-title>Nitric oxide and macrophage function.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>15</volume>: <fpage>323</fpage>&#x02013;<lpage>350</lpage>.<pub-id pub-id-type="pmid">9143691</pub-id></mixed-citation></ref><ref id="r47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrt</surname><given-names>S.</given-names></name><name><surname>Schnappinger</surname><given-names>D.</given-names></name><name><surname>Bekiranov</surname><given-names>S.</given-names></name><name><surname>Drenkow</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>S.</given-names></name><name><surname>Gingeras</surname><given-names>T. R.</given-names></name><name><surname>Gaasterland</surname><given-names>T.</given-names></name><name><surname>Schoolnik</surname><given-names>G.</given-names></name><name><surname>Nathan</surname><given-names>C.</given-names></name></person-group>
<year>2001</year>
<article-title>Reprogramming of the macrophage transcriptome in response to interferon-&#x003b3; and <italic>Mycobacterium tuberculosis</italic>: signaling roles of nitric oxide synthase-2 and phagocyte oxidase.</article-title>
<source>J. Exp. Med.</source>
<volume>194</volume>: <fpage>1123</fpage>&#x02013;<lpage>1140</lpage>.<pub-id pub-id-type="pmid">11602641</pub-id></mixed-citation></ref><ref id="r48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Kasmi</surname><given-names>K. C.</given-names></name><name><surname>Qualls</surname><given-names>J. E.</given-names></name><name><surname>Pesce</surname><given-names>J. T.</given-names></name><name><surname>Smith</surname><given-names>A. M.</given-names></name><name><surname>Thompson</surname><given-names>R. W.</given-names></name><name><surname>Henao-Tamayo</surname><given-names>M.</given-names></name><name><surname>Basaraba</surname><given-names>R. J.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>T.</given-names></name><name><surname>Schleicher</surname><given-names>U.</given-names></name><name><surname>Koo</surname><given-names>M. S.</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.</article-title>
<source>Nat. Immunol.</source>
<volume>9</volume>: <fpage>1399</fpage>&#x02013;<lpage>1406</lpage>.<pub-id pub-id-type="pmid">18978793</pub-id></mixed-citation></ref><ref id="r49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monin</surname><given-names>L.</given-names></name><name><surname>Griffiths</surname><given-names>K. L.</given-names></name><name><surname>Lam</surname><given-names>W. Y.</given-names></name><name><surname>Gopal</surname><given-names>R.</given-names></name><name><surname>Kang</surname><given-names>D. D.</given-names></name><name><surname>Ahmed</surname><given-names>M.</given-names></name><name><surname>Rajamanickam</surname><given-names>A.</given-names></name><name><surname>Cruz-Lagunas</surname><given-names>A.</given-names></name><name><surname>Z&#x000fa;&#x000f1;iga</surname><given-names>J.</given-names></name><name><surname>Babu</surname><given-names>S.</given-names></name><etal/></person-group>
<year>2015</year>
<article-title>Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis.</article-title>
<source>J. Clin. Invest.</source>
<volume>125</volume>: <fpage>4699</fpage>&#x02013;<lpage>4713</lpage>.<pub-id pub-id-type="pmid">26571397</pub-id></mixed-citation></ref><ref id="r50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>P. J.</given-names></name><name><surname>Wynn</surname><given-names>T. A.</given-names></name></person-group>
<year>2011</year>
<article-title>Protective and pathogenic functions of macrophage subsets.</article-title>
<source>Nat. Rev. Immunol.</source>
<volume>11</volume>: <fpage>723</fpage>&#x02013;<lpage>737</lpage>.<pub-id pub-id-type="pmid">21997792</pub-id></mixed-citation></ref><ref id="r51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronte</surname><given-names>V.</given-names></name><name><surname>Zanovello</surname><given-names>P.</given-names></name></person-group>
<year>2005</year>
<article-title>Regulation of immune responses by L-arginine metabolism.</article-title>
<source>Nat. Rev. Immunol.</source>
<volume>5</volume>: <fpage>641</fpage>&#x02013;<lpage>654</lpage>.<pub-id pub-id-type="pmid">16056256</pub-id></mixed-citation></ref><ref id="r52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosu&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Casarini</surname><given-names>M.</given-names></name><name><surname>Alemanno</surname><given-names>L.</given-names></name><name><surname>Galluccio</surname><given-names>G.</given-names></name><name><surname>Mattia</surname><given-names>P.</given-names></name><name><surname>Pedicelli</surname><given-names>G.</given-names></name><name><surname>Rebek</surname><given-names>L.</given-names></name><name><surname>Bisetti</surname><given-names>A.</given-names></name><name><surname>Ameglio</surname><given-names>F.</given-names></name></person-group>
<year>1998</year>
<article-title>Effects of aerosolized interferon-&#x003b1; in patients with pulmonary tuberculosis.</article-title>
<source>Am. J. Respir. Crit. Care Med.</source>
<volume>158</volume>: <fpage>1156</fpage>&#x02013;<lpage>1162</lpage>.<pub-id pub-id-type="pmid">9769275</pub-id></mixed-citation></ref><ref id="r53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmero</surname><given-names>D.</given-names></name><name><surname>Eiguchi</surname><given-names>K.</given-names></name><name><surname>Rendo</surname><given-names>P.</given-names></name><name><surname>Castro Zorrilla</surname><given-names>L.</given-names></name><name><surname>Abbate</surname><given-names>E.</given-names></name><name><surname>Gonz&#x000e1;lez Montaner</surname><given-names>L. J.</given-names></name></person-group>
<year>1999</year>
<article-title>Phase II trial of recombinant interferon-&#x003b1;2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up.</article-title>
<source>Int. J. Tuberc. Lung Dis.</source>
<volume>3</volume>: <fpage>214</fpage>&#x02013;<lpage>218</lpage>.<pub-id pub-id-type="pmid">10094322</pub-id></mixed-citation></ref><ref id="r54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bax</surname><given-names>H. I.</given-names></name><name><surname>Freeman</surname><given-names>A. F.</given-names></name><name><surname>Ding</surname><given-names>L.</given-names></name><name><surname>Hsu</surname><given-names>A. P.</given-names></name><name><surname>Marciano</surname><given-names>B.</given-names></name><name><surname>Kristosturyan</surname><given-names>E.</given-names></name><name><surname>Jancel</surname><given-names>T.</given-names></name><name><surname>Spalding</surname><given-names>C.</given-names></name><name><surname>Pechacek</surname><given-names>J.</given-names></name><name><surname>Olivier</surname><given-names>K. N.</given-names></name><etal/></person-group>
<year>2013</year>
<article-title>Interferon alpha treatment of patients with impaired interferon gamma signaling.</article-title>
<source>J. Clin. Immunol.</source>
<volume>33</volume>: <fpage>991</fpage>&#x02013;<lpage>1001</lpage>.<pub-id pub-id-type="pmid">23512243</pub-id></mixed-citation></ref><ref id="r55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Carroll</surname><given-names>D.</given-names></name><name><surname>Flynn</surname><given-names>J.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group>
<year>1995</year>
<article-title>Effects of nitric oxide synthase inhibitors on murine infection with <italic>Mycobacterium tuberculosis.</italic></article-title>
<source>Infect. Immun.</source>
<volume>63</volume>: <fpage>736</fpage>&#x02013;<lpage>740</lpage>.<pub-id pub-id-type="pmid">7529749</pub-id></mixed-citation></ref><ref id="r56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>M.</given-names></name></person-group>
<year>1991</year>
<article-title>Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates.</article-title>
<source>Cell. Immunol.</source>
<volume>132</volume>: <fpage>150</fpage>&#x02013;<lpage>157</lpage>.<pub-id pub-id-type="pmid">1905984</pub-id></mixed-citation></ref><ref id="r57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J. J.</given-names></name><name><surname>Filla</surname><given-names>M. B.</given-names></name><name><surname>Fultz</surname><given-names>M. J.</given-names></name><name><surname>Vogel</surname><given-names>S. N.</given-names></name><name><surname>Russell</surname><given-names>S. W.</given-names></name><name><surname>Murphy</surname><given-names>W. J.</given-names></name></person-group>
<year>1998</year>
<article-title>Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1&#x003b1; in mouse macrophages: pivotal role of Stat1&#x003b1; in induction of the inducible nitric oxide synthase gene.</article-title>
<source>J. Immunol.</source>
<volume>161</volume>: <fpage>4803</fpage>&#x02013;<lpage>4810</lpage>.<pub-id pub-id-type="pmid">9794412</pub-id></mixed-citation></ref><ref id="r58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>B. B.</given-names></name><name><surname>Rathinam</surname><given-names>V. A.</given-names></name><name><surname>Martens</surname><given-names>G. W.</given-names></name><name><surname>Martinot</surname><given-names>A. J.</given-names></name><name><surname>Kornfeld</surname><given-names>H.</given-names></name><name><surname>Fitzgerald</surname><given-names>K. A.</given-names></name><name><surname>Sassetti</surname><given-names>C. M.</given-names></name></person-group>
<year>2013</year>
<article-title>Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1&#x003b2;.</article-title>
<source>Nat. Immunol.</source>
<volume>14</volume>: <fpage>52</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">23160153</pub-id></mixed-citation></ref><ref id="r59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pessanha</surname><given-names>A. P.</given-names></name><name><surname>Martins</surname><given-names>R. A.</given-names></name><name><surname>Mattos-Guaraldi</surname><given-names>A. L.</given-names></name><name><surname>Vianna</surname><given-names>A.</given-names></name><name><surname>Moreira</surname><given-names>L. O.</given-names></name></person-group>
<year>2012</year>
<article-title>Arginase-1 expression in granulomas of tuberculosis patients.</article-title>
<source>FEMS Immunol. Med. Microbiol.</source>
<volume>66</volume>: <fpage>265</fpage>&#x02013;<lpage>268</lpage>.<pub-id pub-id-type="pmid">22827286</pub-id></mixed-citation></ref><ref id="r60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qualls</surname><given-names>J. E.</given-names></name><name><surname>Neale</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>A. M.</given-names></name><name><surname>Koo</surname><given-names>M. S.</given-names></name><name><surname>DeFreitas</surname><given-names>A. A.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Kaplan</surname><given-names>G.</given-names></name><name><surname>Watowich</surname><given-names>S. S.</given-names></name><name><surname>Murray</surname><given-names>P. J.</given-names></name></person-group>
<year>2010</year>
<article-title>Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling.</article-title>
<source>Sci. Signal.</source>
<volume>3</volume>: <fpage>ra62</fpage>.<pub-id pub-id-type="pmid">20716764</pub-id></mixed-citation></ref><ref id="r61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanasen</surname><given-names>N.</given-names></name><name><surname>Soong</surname><given-names>L.</given-names></name></person-group>
<year>2008</year>
<article-title>L-arginine metabolism and its impact on host immunity against <italic>Leishmania</italic> infection.</article-title>
<source>Immunol. Res.</source>
<volume>41</volume>: <fpage>15</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">18040886</pub-id></mixed-citation></ref><ref id="r62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahnert</surname><given-names>A.</given-names></name><name><surname>Seiler</surname><given-names>P.</given-names></name><name><surname>Stein</surname><given-names>M.</given-names></name><name><surname>Bandermann</surname><given-names>S.</given-names></name><name><surname>Hahnke</surname><given-names>K.</given-names></name><name><surname>Mollenkopf</surname><given-names>H.</given-names></name><name><surname>Kaufmann</surname><given-names>S. H.</given-names></name></person-group>
<year>2006</year>
<article-title>Alternative activation deprives macrophages of a coordinated defense program to <italic>Mycobacterium tuberculosis.</italic></article-title>
<source>Eur. J. Immunol.</source>
<volume>36</volume>: <fpage>631</fpage>&#x02013;<lpage>647</lpage>.<pub-id pub-id-type="pmid">16479545</pub-id></mixed-citation></ref><ref id="r63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potian</surname><given-names>J. A.</given-names></name><name><surname>Rafi</surname><given-names>W.</given-names></name><name><surname>Bhatt</surname><given-names>K.</given-names></name><name><surname>McBride</surname><given-names>A.</given-names></name><name><surname>Gause</surname><given-names>W. C.</given-names></name><name><surname>Salgame</surname><given-names>P.</given-names></name></person-group>
<year>2011</year>
<article-title>Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway.</article-title>
<source>J. Exp. Med.</source>
<volume>208</volume>: <fpage>1863</fpage>&#x02013;<lpage>1874</lpage>.<pub-id pub-id-type="pmid">21825018</pub-id></mixed-citation></ref><ref id="r64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heitmann</surname><given-names>L.</given-names></name><name><surname>Abad Dar</surname><given-names>M.</given-names></name><name><surname>Schreiber</surname><given-names>T.</given-names></name><name><surname>Erdmann</surname><given-names>H.</given-names></name><name><surname>Behrends</surname><given-names>J.</given-names></name><name><surname>Mckenzie</surname><given-names>A. N.</given-names></name><name><surname>Brombacher</surname><given-names>F.</given-names></name><name><surname>Ehlers</surname><given-names>S.</given-names></name><name><surname>H&#x000f6;lscher</surname><given-names>C.</given-names></name></person-group>
<year>2014</year>
<article-title>The IL-13/IL-4R&#x003b1; axis is involved in tuberculosis-associated pathology.</article-title>
<source>J. Pathol.</source>
<volume>234</volume>: <fpage>338</fpage>&#x02013;<lpage>350</lpage>.<pub-id pub-id-type="pmid">24979482</pub-id></mixed-citation></ref><ref id="r65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kratochvill</surname><given-names>F.</given-names></name><name><surname>Neale</surname><given-names>G.</given-names></name><name><surname>Haverkamp</surname><given-names>J. M.</given-names></name><name><surname>Van de Velde</surname><given-names>L. A.</given-names></name><name><surname>Smith</surname><given-names>A. M.</given-names></name><name><surname>Kawauchi</surname><given-names>D.</given-names></name><name><surname>McEvoy</surname><given-names>J.</given-names></name><name><surname>Roussel</surname><given-names>M. F.</given-names></name><name><surname>Dyer</surname><given-names>M. A.</given-names></name><name><surname>Qualls</surname><given-names>J. E.</given-names></name><name><surname>Murray</surname><given-names>P. J.</given-names></name></person-group>
<year>2015</year>
<article-title>TNF counterbalances the emergence of M2 tumor macrophages.</article-title>
<source>Cell Reports</source>
<volume>12</volume>: <fpage>1902</fpage>&#x02013;<lpage>1914</lpage>.<pub-id pub-id-type="pmid">26365184</pub-id></mixed-citation></ref><ref id="r66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>T.</given-names></name><name><surname>Ehlers</surname><given-names>S.</given-names></name><name><surname>Heitmann</surname><given-names>L.</given-names></name><name><surname>Rausch</surname><given-names>A.</given-names></name><name><surname>Mages</surname><given-names>J.</given-names></name><name><surname>Murray</surname><given-names>P. J.</given-names></name><name><surname>Lang</surname><given-names>R.</given-names></name><name><surname>H&#x000f6;lscher</surname><given-names>C.</given-names></name></person-group>
<year>2009</year>
<article-title>Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity.</article-title>
<source>J. Immunol.</source>
<volume>183</volume>: <fpage>1301</fpage>&#x02013;<lpage>1312</lpage>.<pub-id pub-id-type="pmid">19561100</pub-id></mixed-citation></ref></